Inactive Instrument

LivaNova PLC Share Price London S.E.

Equities

LIVN

GB00BYMT0J19

Medical Equipment, Supplies & Distribution

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.22B 95.73B Sales 2025 * 1.28B 101B Capitalization 3.31B 260B
Net income 2024 * 39M 3.07B Net income 2025 * 91M 7.17B EV / Sales 2024 * 2.64 x
Net cash position 2024 * 102M 8.05B Net cash position 2025 * 231M 18.16B EV / Sales 2025 * 2.41 x
P/E ratio 2024 *
88.8 x
P/E ratio 2025 *
35.7 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.87%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO 54 31/12/16
Chairman 72 11/06/18
Chief Tech/Sci/R&D Officer - 07/01/18
Members of the board TitleAgeSince
Director/Board Member 63 02/12/20
Director/Board Member 64 12/06/22
Chairman 72 11/06/18
More insiders
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.
Related indices
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW